Demand for viral vector vaccines is set to reach US$ 1.23 billion by the end of 2033. Advancements in technology have allowed for the creation of more efficient and safer viral vector vaccines. Use of viral vectors in gene therapy has led to the expansion of viral vector technology beyond traditional vaccine development. Key Takeaways from Market StudyThe global viral vector vaccines market is predicted to reach a valuation of US$ 1.23 billion by the end of 2033. Other Trending Reports:About Persistence Market Research:Business intelligence is the foundation of every business model employed by Persistence Market Research.

Source: The North Africa Journal May 20, 2023 01:11 UTC